Japanese Price Revision Debate Will Address 10 Product Categories
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will oppose foreign average price (FAP) revisions to PTCA catheters in arguments before Japan's Ministry of Health, Labor & Welfare Chuikyo advisory panel Jan. 15
You may also be interested in...
International Memoranda Of Understanding To Bridge Regulatory Divide – FDA
FDA will develop additional Memoranda of Understanding this year, based on other nations' increased product trade with the U.S. and FDA's ability to leverage resources with various regulatory agencies
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.